Enhancing innate immunity against virus in times of COVID-19: Trying to untangle facts from fictions

Abstract

Introduction In the light of the current COVID-19 pandemic, during which the world is confronted with a new, highly contagious virus that suppresses innate immunity as one of its initial virulence mechanisms, thus escaping from the first-line human defense mechanisms, enhancing innate immunity seems a good preventive strategy. Methods Without the intention to write an official systematic review, but more to give an overview of possible strategies, in this review article we discuss several interventions that might stimulate innate immunity and thus our defense against (viral) respiratory tract infections. Some of these interventions can also stimulate the adaptive T- and B-cell responses, but our main focus is on the innate part of immunity. We divide the reviewed interventions in: 1) lifestyle related (exercise, >7 hours sleep, forest walking, meditation/mindfulness, vitamin supplementation); 2) Non-specific immune stimulants (letting fever advance, bacterial vaccines, probiotics, dialyzable leukocyte extract, pidotimod) and 3) specific vaccines with heterologous effect (BCG vaccine, mumps-measles-rubeola vaccine, i.e.). Results For each of these interventions we briefly comment on their definition, possible mechanisms and evidence of clinical efficacy or lack of it, especially focusing on respiratory tract infections, viral infections and eventually a reduced mortality in severe respiratory infections in the intensive care unit. At the end a summary table demonstrates the best trials supporting (or not) clinical evidence. Conclusion Several interventions have some degree of evidence for enhancing the innate immune response and thus conveying possible benefit, but specific trials in COVID-19 should be conducted to support solid recommendations.

Efficiency of application of sorbed probiotics in complex therapy of pneumonia caused by SARS-CoV-2. Part 1. Heating clinical displays period

“…и D. Larenas-Linnemann и соавт. [12,13]. На сайте ClinicalTrials.gov (режим доступа: https://www.clinicaltrials.…”

An urgent proposal for the immediate use of melatonin as an adjuvant to anti- SARS-CoV-2 vaccination

“…In a recent publication, several interventions that might stimulate innate immunity against (viral) respiratory tract infections were reviewed (12). Interventions included lifestyle-related (exercise, >7 h sleep, forest walking, meditation/mindfulness, vitamin supplementation), nonspecific immune stimulants (letting fever advance, bacterial vaccines, probiotics, dialyzable leukocyte extract, pidotimod), and specific vaccines with heterologous effect (BCG vaccine, mumps-measles-rubeola vaccine).…”

Microglial Implications in SARS-CoV-2 Infection and COVID-19: Lessons From Viral RNA Neurotropism and Possible Relevance to Parkinson’s Disease

“…Although DNA viruses and retroviruses, via dsDNA, activate this pathway, emerging evidence indicates that positive-stranded RNA viruses can evade immune recognition by suppressing the STING pathway. Positive-stranded RNA viruses seem to interfere with the innate defense mechanisms by disrupting IFN production and its effects ( Kabir et al, 2020 ; Larenas-Linnemann et al, 2020 ). For instance, the cleavage of STING by non-structural protein (NS) 2B and NS3 proteins was recognized as a conserved strategy used by flavivirus including dengue virus (DENV), WNV, ZIKV, and Japanese encephalitis virus (JEV) to establish infections in human ( Aguirre et al, 2012 ; Yu et al, 2012 ; Ding et al, 2018 ).…”